Isosorbide mononitrate and Sputum discolored - a phase IV clinical study of FDA data

Summary:

Sputum discolored is reported as a side effect among people who take Isosorbide mononitrate (isosorbide mononitrate), especially for people who are male, 60+ old, also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Sputum discolored when taking Isosorbide mononitrate. It is created by eHealthMe based on reports of 26,444 people who have side effects when taking Isosorbide mononitrate from the FDA, and is updated regularly.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.

What is Sputum discolored?

Sputum discolored is found to be associated with 910 drugs and 558 conditions by eHealthMe. Check the latest studies of Sputum discolored.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 13, 2026

26,444 people reported to have side effects when taking Isosorbide mononitrate.
Among them, 49 people (0.19%) have Sputum discolored.

Could Isosorbide mononitrate cause Sputum discolored?

Among these 49 people:

What is the gender of people who have Sputum discolored when taking Isosorbide mononitrate? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Sputum discolored when taking Isosorbide mononitrate? *

What are other drugs people take besides Isosorbide mononitrate? *

What are other side effects people have besides Sputum discolored? *

Cough: 35 people, 71.43%
Chest Pain: 26 people, 53.06%
Pneumonia: 25 people, 51.02%
Hypotension (abnormally low blood pressure): 20 people, 40.82%
Drug Ineffective: 19 people, 38.78%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 16 people, 32.65%
Peripheral Coldness: 16 people, 32.65%
Neck Pain: 16 people, 32.65%
Oropharyngeal Pain: 16 people, 32.65%
Thrombocytopenia (decrease of platelets in blood): 16 people, 32.65%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 28.57%
Asthma: 10 people, 20.41%
Restless Leg Syndrome (a powerful urge to move your legs): 9 people, 18.37%
Depression: 8 people, 16.33%
Cardiac Disorder: 7 people, 14.29%
Gastritis (inflammation of stomach): 5 people, 10.20%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 10.20%
Pain: 5 people, 10.20%
Diabetes: 4 people, 8.16%
Tuberculosis Of Central Nervous System (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and have Sputum discolored?

- Check whether Sputum discolored is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isosorbide mononitrate:

Isosorbide mononitrate (26,858 reports)

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sputum discolored:

Sputum discolored (910 drugs)

Browse all the conditions that are associated with Sputum discolored:

Sputum discolored (558 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate (the active ingredients of Isosorbide mononitrate) and Isosorbide mononitrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.